AtriCure (ATRC) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.10 -1.73%
Revenue Growth %: +12.6%
Financial Fact:
Interest expense: -530K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +12.6%
Financial Fact:
Interest expense: -530K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $37.85 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
